Ghofrani H, Simonneau G, D'Armini AM, et al. Efficacy and Safety of Macitentan for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Results from the Randomized Controlled MERIT Study. ATS 2017, A7601.
Anti-C5a-antilichaam vilobelimab veilig bij ernstige COVID-19
feb 2021 | Pneumonie, Virale infecties